In order to effectively protect consumers, markets and manufacturers from counterfeits, a legally binding framework for tracing prescription-only medicines was created, for example, with the EU Falsified Medicines Directive (FMD) of 2011 and the Delegated Regulation (EU) 2016/161. Among other things, data matrix codes, database comparisons with national verification systems and solutions for detecting the integrity of product packaging are used. A central element in the fight against counterfeit medicines is digitisation. The Arvato CSDB is used as a proven serialisation solution by over 80 pharmaceutical companies and ensures both a smooth serialisation process and the seamless implementation of legal requirements. We are also an official Blueprint Service Provider of the European Medicines Verification Organisation (EMVO). More Information: https://arvato-systems.com/arvatocsdb